Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    F-star Therapeutics Inc.

    NASDAQ: FSTX · Real-Time Price · USD
    7.12
    0.00 (0.00%)
    At close: Mar 08, 2023, 10:00 PM

    F-star Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 1.13M n/a 2.55M 17.5M 751K n/a 2.92M
    Cost of Revenue
    		 n/a n/a n/a n/a n/a n/a n/a
    Gross Profit
    		 1.13M n/a 2.55M 17.5M 751K n/a 2.92M
    Operating Income
    		 -13.71M -16.18M -11.19M 4.18M -9.6M -14.94M -10.78M
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 -18.41M -18.99M -12.09M 4.18M -10.79M -15.57M -9.76M
    Net Income
    		 -18.47M -19.12M -12.14M 4.74M -10.79M -15.65M -9.87M
    Selling & General & Admin
    		 5.16M 7.46M 5.7M 4.96M 5.24M 6.5M 6.43M
    Research & Development
    		 9.67M 8.72M 8.04M 8.21M 5.11M 8.44M 7.27M
    Other Expenses
    		 n/a n/a n/a n/a n/a n/a n/a
    Operating Expenses
    		 14.83M 16.18M 13.74M 13.18M 10.35M 14.94M 13.7M
    Interest Expense
    		 378K 334K 308K -844K n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 14.83M 16.18M 13.74M 13.18M 10.35M 14.94M 13.7M
    Income Tax Expense
    		 60K 127K 58K -562K n/a 82K 108K
    Shares Outstanding (Basic)
    		 21.86M 21.57M 21.08M 20.62M 20.62M 17.02M 9.1M
    Shares Outstanding (Diluted)
    		 21.86M 21.57M 21.08M 20.62M 20.62M 17.02M 9.1M
    EPS (Basic)
    		 -0.84 -0.89 -0.58 0.23 -0.52 -0.92 -1.08
    EPS (Diluted)
    		 -0.84 -0.89 -0.58 0.23 -0.52 -0.92 -1.08
    EBITDA
    		 -17.78M -18.38M -11.53M 3.57M -9.84M -15.41M -9.62M
    EBIT
    		 -18.03M -18.66M -11.78M 3.19M n/a n/a n/a
    Depreciation & Amortization
    		 -4.07M -2.2M -346K -607K 952K 153K 144K

    Add to Watchlist